Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

<p>COVID-19 vaccine efficacy (VE) has been observed to vary against antigenically distinct SARS-CoV-2 variants of concern (VoC). Here we report the final analysis of VE and safety from COV005: a phase 1b/2, multicenter, double-blind, randomized, placebo-controlled study of primary series AZD12...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Koen, AL, Izu, A, Baillie, V, Kwatra, G, Cutland, CL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Ahmed, K, Bhikha, S, Bhiman, JN, du Plessis, J, Esmail, A, Horne, E, Hwa, S-H, Oommen-Jose, A, Lambe, T, Laubscher, M, Malahleha, M, Benade, G, McKenzie, S, Oelofse, S, Patel, F, Pillay, S, Rhead, S, Rodel, H, Taoushanis, C, Tegally, H, Thombrayil, A, Villafana, TL, Gilbert, S, Pollard, AJ, Madhi, SA
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: Elsevier 2023

Những quyển sách tương tự